Stéphane Bancel, MarketsModerna Cutting 10% of Workforce Amid Revenue Woes100% center coverage2 sources
Stéphane Bancel, MarketsModerna Cutting 10% of Workforce Amid Revenue Woes100% center coverage2 sources
Stéphane Bancel, FDAFDA Grants Full Approval to Moderna COVID Vaccine for At-Risk Children50% left coverage2 sources
Stéphane Bancel, FDAFDA Grants Full Approval to Moderna COVID Vaccine for At-Risk Children50% left coverage2 sources
Stéphane BancelModerna seeks outside funding for late-stage vaccine trials100% left coverage2 sources
Stéphane BancelModerna seeks outside funding for late-stage vaccine trials100% left coverage2 sources
Stéphane BancelFDA Approves Moderna COVID Vaccine for Older, High-Risk Adults100% left coverage1 source
Stéphane BancelFDA Approves Moderna COVID Vaccine for Older, High-Risk Adults100% left coverage1 source
Stéphane Bancel, CoronavirusFDA Approves Moderna Low-Dose COVID Vaccine for Older, High-Risk Adults50% left coverage2 sources
Stéphane Bancel, CoronavirusFDA Approves Moderna Low-Dose COVID Vaccine for Older, High-Risk Adults50% left coverage2 sources
Stéphane Bancel, Avian FluHHS Revokes Moderna Funding Despite Positive H5 Avian Flu Trial100% left coverage1 source
Stéphane Bancel, Avian FluHHS Revokes Moderna Funding Despite Positive H5 Avian Flu Trial100% left coverage1 source